ARCHIVES

L-PAM Benefit To Post-Menopausal Patients Challenged

This article is from The Cancer Letter archive.

Vol. 02 No. 44 | October 29, 1976

Download PDF Visit The Full Archive

Related Articles

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

Correcting the Error: What U.S. News Could and Couldn’t Do to Fix the Problem

July 19, 2013

Breast Cancer Researchers Plan Collaborative Studies

February 27, 2004

Zerhouni Starts Work As NIH Director

May 24, 2002

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

Antman, Clanton begin work at NCI.

December 5, 2003